Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bo Torben Porse

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Nature Communications|January 13, 2019
The splicing factor RBM25 controls MYC activity in acute myeloid leukemiaYing Ge, Mikkel Bruhn Schuster, Sachin Pundhir, et al.
Nucleic Acids Research|November 7, 2023
BloodSpot 3.0: a database of gene and protein expression data in normal and malignant haematopoiesisMagnús H Gíslason, Gül Sude Demircan, Marek Prachar, et al.
Genes & Development|May 17, 2008
NMD is essential for hematopoietic stem and progenitor cells and for eliminating by-products of programmed DNA rearrangementsJoachim Weischenfeldt, Inge Damgaard, David Bryder, et al.
Molecular and Cellular Biology|January 24, 2006
The proline-histidine-rich CDK2/CDK4 interaction region of C/EBPalpha is dispensable for C/EBPalpha-mediated growth regulation in vivoBo Torben Porse, Thomas Askov Pedersen, Marie Sigurd Hasemann, et al.
Leukemia|December 10, 2020
Targeted inhibition of cooperative mutation- and therapy-induced AKT activation in AML effectively enhances response to chemotherapyMontserrat Estruch, Kristian Reckzeh, Camilla Vittori, et al.
Cell Reports|May 31, 2018
Enhancer and Transcription Factor Dynamics during Myeloid Differentiation Reveal an Early Differentiation Block in Cebpa null ProgenitorsSachin Pundhir, Felicia Kathrine Bratt Lauridsen, Mikkel Bruhn Schuster, et al.
Science Advances|March 18, 2022
H3K9 dimethylation safeguards cancer cells against activation of the interferon pathwayAnne Meldgaard Hansen, Ying Ge, Mikkel Bruhn Schuster, et al.
Cell Reports|July 19, 2018
Differences in Cell Cycle Status Underlie Transcriptional Heterogeneity in the HSC CompartmentFelicia Kathrine Bratt Lauridsen, Tanja Lyholm Jensen, Nicolas Rapin, et al.
Cell Research|January 9, 2019
A programmed wave of uridylation-primed mRNA degradation is essential for meiotic progression and mammalian spermatogenesisMarcos Morgan, Yuka Kabayama, Christian Much, et al.
Genes & Development|September 20, 2015
ERG promotes the maintenance of hematopoietic stem cells by restricting their differentiationKasper Jermiin Knudsen, Matilda Rehn, Marie Sigurd Hasemann, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Nature Communications|January 13, 2019
The splicing factor RBM25 controls MYC activity in acute myeloid leukemiaYing Ge, Mikkel Bruhn Schuster, Sachin Pundhir, et al.
Nucleic Acids Research|November 7, 2023
BloodSpot 3.0: a database of gene and protein expression data in normal and malignant haematopoiesisMagnús H Gíslason, Gül Sude Demircan, Marek Prachar, et al.
Genes & Development|May 17, 2008
NMD is essential for hematopoietic stem and progenitor cells and for eliminating by-products of programmed DNA rearrangementsJoachim Weischenfeldt, Inge Damgaard, David Bryder, et al.
Molecular and Cellular Biology|January 24, 2006
The proline-histidine-rich CDK2/CDK4 interaction region of C/EBPalpha is dispensable for C/EBPalpha-mediated growth regulation in vivoBo Torben Porse, Thomas Askov Pedersen, Marie Sigurd Hasemann, et al.
Leukemia|December 10, 2020
Targeted inhibition of cooperative mutation- and therapy-induced AKT activation in AML effectively enhances response to chemotherapyMontserrat Estruch, Kristian Reckzeh, Camilla Vittori, et al.
Cell Reports|May 31, 2018
Enhancer and Transcription Factor Dynamics during Myeloid Differentiation Reveal an Early Differentiation Block in Cebpa null ProgenitorsSachin Pundhir, Felicia Kathrine Bratt Lauridsen, Mikkel Bruhn Schuster, et al.
Science Advances|March 18, 2022
H3K9 dimethylation safeguards cancer cells against activation of the interferon pathwayAnne Meldgaard Hansen, Ying Ge, Mikkel Bruhn Schuster, et al.
Cell Reports|July 19, 2018
Differences in Cell Cycle Status Underlie Transcriptional Heterogeneity in the HSC CompartmentFelicia Kathrine Bratt Lauridsen, Tanja Lyholm Jensen, Nicolas Rapin, et al.
Cell Research|January 9, 2019
A programmed wave of uridylation-primed mRNA degradation is essential for meiotic progression and mammalian spermatogenesisMarcos Morgan, Yuka Kabayama, Christian Much, et al.
Genes & Development|September 20, 2015
ERG promotes the maintenance of hematopoietic stem cells by restricting their differentiationKasper Jermiin Knudsen, Matilda Rehn, Marie Sigurd Hasemann, et al.
Pageof 3